Received Jan 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | YN2X2 | — |
16-month-old patient was administered a dose of the Kinrix vaccine; This non-serious case was reported by the other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 16-month-old female patient who received DTPa-IPV (Kinrix) (batch number YN2X2, expiry date 16-OCT-2026) for prophylaxis. On an unknown date, the patient received Kinrix. On an unknown date, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 16-month-old patient was administered a dose of the Kinrix vaccine). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 06-JAN-2026 A 16-month-old patient was administered a dose of the Kinrix vaccine. The patient had 3 doses of Dtap and IPV previously.